In vitro comparison of A-56619, A-56620, amifloxacin, ciprofloxacin, enoxacin, norfloxacin, and ofloxacin against methicillin-resistant Staphylococcus aureus
about
Whole animal automated platform for drug discovery against multi-drug resistant Staphylococcus aureusOfloxacin: its pharmacology, pharmacokinetics, and potential for clinical application.Clinical importance and epidemiology of quinolone resistance.Ciprofloxacin therapy for methicillin-resistant Staphylococcus aureus infections or colonizations.Widespread quinolone resistance among methicillin-resistant Staphylococcus aureus isolates in a general hospitalIn vitro activities of amifloxacin and two of its metabolites.Comparison of in vitro activity of quinolone antibiotics and vancomycin against gentamicin- and methicillin-resistant Staphylococcus aureus by time-kill kinetic studies.Nontypeable bacteriophage patterns of methicillin-resistant Staphylococcus aureus involved in a hospital outbreak.Penetration of moxifloxacin into bone evaluated by Monte Carlo simulation.Comparative evaluation of identification systems for testing methicillin-resistant strains of Staphylococcus aureus.Topical ofloxacin compared with gentamicin in the treatment of external ocular infection. Ofloxacin Study Group.A review of the antimicrobial activity of the fluoroquinolones.Ciprofloxacin: chemistry, mechanism of action, resistance, antimicrobial spectrum, pharmacokinetics, clinical trials, and adverse reactions.Mode of action, and in vitro and in vivo activities of the fluoroquinolones.In vitro activity of AT-4140 against clinical bacterial isolates.Ciprofloxacin versus vancomycin in the therapy of experimental methicillin-resistant Staphylococcus aureus endocarditis.Differing activities of quinolones against ciprofloxacin-susceptible and ciprofloxacin-resistant, methicillin-resistant Staphylococcus aureus.Methicillin-resistant strains of Staphylococcus aureus resistant to quinolones.In vitro susceptibilities of rapidly growing mycobacteria to newer antimicrobial agents.Macrolides: problems and promises.
P2860
Q28539903-0498905C-4F7A-4048-9382-C980C3DA8D66Q34687048-69B6913D-338A-48B8-A78B-7384E44DE1DAQ34838791-935D8020-AFE4-4FAE-AEA4-29EC7FB78AC1Q35244236-36207E23-EC4F-4149-A762-4EC42DA5D2C0Q35329548-A27CFCDF-257E-437B-8D48-38A9E541059DQ35334146-0D03D643-2163-4080-B834-CFBC9FE529B7Q35653503-C65DEF98-DBD5-4C47-8107-2A2FCC6574D7Q37160739-22845CE5-2860-43DE-89AA-DE2065A7326EQ37190660-FE7C6812-4F3B-4749-8A96-9AEFBE4FD976Q37208109-BA2F3898-2B3F-41C6-9750-679EE447480EQ37299512-FA0B78DA-E087-49EE-959F-51C27DE1807FQ37834318-11964D2C-83B1-4C5C-91BC-B27AF9AFDE26Q39214819-AA3144B6-6221-4A19-B639-C57D93BC963BQ39637667-25AA1637-6035-43E6-97A6-9665FD99B2B1Q39820328-1A3FE4CD-9431-452C-ABEB-34A4CE8929D1Q39827957-77453EA8-B544-483A-88CB-20165E8A2CE9Q40085890-E9C147E4-1ED7-4A80-AA02-F7D6D16BA7ACQ40198546-E97FA781-BB16-47DA-AACE-D0277636F5C5Q40284828-0044D3E4-D5EB-4EBB-80EF-F90257F93985Q54388935-E2A0C8A4-87F7-4A19-ADF8-A00EA00CDFA4
P2860
In vitro comparison of A-56619, A-56620, amifloxacin, ciprofloxacin, enoxacin, norfloxacin, and ofloxacin against methicillin-resistant Staphylococcus aureus
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年学术文章
@wuu
1986年学术文章
@zh-cn
1986年学术文章
@zh-hans
1986年学术文章
@zh-my
1986年学术文章
@zh-sg
1986年學術文章
@yue
1986年學術文章
@zh
1986年學術文章
@zh-hant
name
In vitro comparison of A-56619 ...... esistant Staphylococcus aureus
@en
In vitro comparison of A-56619 ...... sistant Staphylococcus aureus.
@nl
type
label
In vitro comparison of A-56619 ...... esistant Staphylococcus aureus
@en
In vitro comparison of A-56619 ...... sistant Staphylococcus aureus.
@nl
prefLabel
In vitro comparison of A-56619 ...... esistant Staphylococcus aureus
@en
In vitro comparison of A-56619 ...... sistant Staphylococcus aureus.
@nl
P2860
P356
P1476
In vitro comparison of A-56619 ...... esistant Staphylococcus aureus
@en
P2093
P2860
P304
P356
10.1128/AAC.29.2.325
P407
P577
1986-02-01T00:00:00Z